Atriva Therapeutics GmbH: Germany: EIB backs Atriva Therapeutics with €24 million for the development of a potential COVID-19 treatment

HepaRegeniX GmbH hires industry veteran Dr David Shapiro as Senior Medical Advisor

Adocia Announces Third Quarter 2020 Financial Results

CEVEC and Rznomics sign license agreement for the use of CAP® Technology in manufacturing of adenoviral vectors

CENTOGENE GmbH: CENTOGENE Receives FDA Emergency Use Authorization for SARS-CoV-2 RT-PCR Assay for Individuals Without Symptoms or Other Reasons to Suspect COVID-19

Media Advisory: BIO-Europe® Digital | October 26–29, 2020 | European Standard Time

Topas Therapeutics Raises €22 Million (~USD 26 Million) in Series B Financing

Topas Therapeutics Appoints Klaus Martin, Ph.D. as Chief Executive Officer

CENTOGENE GmbH: Kooperation zwischen CENTOGENE und U-Diagnostics verstärkt COVID-19 Testkapazitäten in den Niederlanden

CENTOGENE GmbH: Collaboration Between CENTOGENE and U-Diagnostics Increases COVID-19 Testing Capacities in the Netherlands Information Security Management System Awarded ISO/IEC 27001:2017 Accreditation